SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-21-000010
Filing Date
2021-08-16
Accepted
2021-08-16 07:07:05
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20210630.htm   iXBRL 10-Q 1959809
2 EX-31.1 a20210630exhibit311.htm EX-31.1 9180
3 EX-31.2 a20210630exhibit312.htm EX-31.2 11356
4 EX-32.1 a20210630exhibit321.htm EX-32.1 5113
5 EX-32.2 a20210630exhibit322.htm EX-32.2 4726
  Complete submission text file 0001847903-21-000010.txt   6922395

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20210630.xsd EX-101.SCH 48087
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20210630_cal.xml EX-101.CAL 60253
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20210630_def.xml EX-101.DEF 241976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20210630_lab.xml EX-101.LAB 578711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20210630_pre.xml EX-101.PRE 381666
11 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20210630_htm.xml XML 875743
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 211174462
SIC: 2834 Pharmaceutical Preparations